News & Updates

Bladder cycling pretransplant offers no clinical advantage in patients with defunctionalized bladder

24 Jan 2023

For patients with defunctionalized bladder, bladder cycling prior to renal transplant does little to improve outcomes such as postoperative urological complication, urodynamic criteria, and graft function and survival, according to a study.

Bladder cycling pretransplant offers no clinical advantage in patients with defunctionalized bladder

24 Jan 2023

Efgartigimod tied to sustained platelet count increase in patients with ITP

24 Jan 2023 by

Treatment with efgartigimod, a neonatal Fc receptor (FcRn) antagonist, in patients with chronic or persistent immune thrombocytopenia (ITP) resulted in a higher proportion of patients achieving a sustained platelet count response compared with placebo, according to the ADVANCE IV* trial presented at ASH 2022.

Efgartigimod tied to sustained platelet count increase in patients with ITP

24 Jan 2023

Finerenone reduces SBP in diabetic patients with CKD

23 Jan 2023

Treatment with finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist with a short half-life, results in decreased 24-h, daytime, and night-time systolic blood pressure (SBP), results of a study have shown.

Finerenone reduces SBP in diabetic patients with CKD

23 Jan 2023

Objective response to systemic therapy linked to overall survival in unresectable HCC

23 Jan 2023 by

Objective response to first-line systemic therapy with lenvatinib or sorafenib independently predicts overall survival (OS) in individuals with unresectable hepatocellular carcinoma (HCC), as shown by the subanalysis of the REFLECT study.

Objective response to systemic therapy linked to overall survival in unresectable HCC

23 Jan 2023

Higher HCQ dose ups incident retinopathy risk

23 Jan 2023

A recent study reports an overall risk of 8.6 percent for hydroxychloroquine (HCQ) retinopathy after 15 years in a large cohort with active surveillance retinopathy screening. Notably, most of these cases are mild, and a higher HCQ dose appears to result in progressively greater risk for incident retinopathy.

Higher HCQ dose ups incident retinopathy risk

23 Jan 2023

Infections a risk factor for dementia

23 Jan 2023

Individuals who have been hospitalized with infection appear to be at higher risk of dementia compared with their peers who are unexposed to infections, as reported in a study.

Infections a risk factor for dementia

23 Jan 2023

Device filters out direct thrombin inhibitor from plasma for routine haemostasis tests

23 Jan 2023 by

A user-friendly medical device can effectively remove the direct thrombin inhibitor (DTI) argatroban from plasma in a rapid and ergonomic manner, as shown in the results of a study presented at ASH 2022.

Device filters out direct thrombin inhibitor from plasma for routine haemostasis tests

23 Jan 2023

Rituximab confers cardioprotection on pemphigus patients

23 Jan 2023

Treatment with rituximab in patients with pemphigus appears to yield long-term cardiovascular and metabolic protection as compared with conventional immunosuppressants, a study has shown.

Rituximab confers cardioprotection on pemphigus patients

23 Jan 2023

Multiple moles, genetic predisposition up risk of second primary melanomas

22 Jan 2023

Individuals with multiple nevi and high genetic predisposition to melanoma appear to have the highest risks of developing second primary melanomas, according to a study.

Multiple moles, genetic predisposition up risk of second primary melanomas

22 Jan 2023

Monitoring Epstein–Barr viral load may reduce PTLD incidence after liver transplant

22 Jan 2023

Epstein‒Barr virus (EBV) viral load (VL) monitoring can help lower the incidence of post-transplant lymphoproliferative disease (PTLD) following liver transplant in adults, suggests a study.

Monitoring Epstein–Barr viral load may reduce PTLD incidence after liver transplant

22 Jan 2023

News & Updates

Filter by Specialty:

Specialty:

Bladder cycling pretransplant offers no clinical advantage in patients with defunctionalized bladder

Bladder cycling pretransplant offers no clinical advantage in patients with defunctionalized bladder

Efgartigimod tied to sustained platelet count increase in patients with ITP

Efgartigimod tied to sustained platelet count increase in patients with ITP

Finerenone reduces SBP in diabetic patients with CKD

Finerenone reduces SBP in diabetic patients with CKD

Objective response to systemic therapy linked to overall survival in unresectable HCC

Objective response to systemic therapy linked to overall survival in unresectable HCC

Higher HCQ dose ups incident retinopathy risk

Higher HCQ dose ups incident retinopathy risk

Infections a risk factor for dementia

Infections a risk factor for dementia

Device filters out direct thrombin inhibitor from plasma for routine haemostasis tests

Device filters out direct thrombin inhibitor from plasma for routine haemostasis tests

Rituximab confers cardioprotection on pemphigus patients

Rituximab confers cardioprotection on pemphigus patients

Multiple moles, genetic predisposition up risk of second primary melanomas

Multiple moles, genetic predisposition up risk of second primary melanomas

Monitoring Epstein–Barr viral load may reduce PTLD incidence after liver transplant

Monitoring Epstein–Barr viral load may reduce PTLD incidence after liver transplant